Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:â¯ II. Therapies for allergic bronchopulmonary aspergillosis.

Epps, Quovadis J; Epps, Kevin L; Zobell, Jeffery T; Young, David C

Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:â¯ II. Therapies for allergic bronchopulmonary aspergillosis.

Epps, Quovadis J; Epps, Kevin L; Zobell, Jeffery T; Young, David C.

Afiliación

Epps QJ; Florida Agricultural and Mechanical University College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Jacksonville, Florida, USA.
Epps KL; Department of Pharmacy, The Mayo Clinic, Jacksonville, Florida, USA.
Zobell JT; Department of Pharmacy, Intermountain Primary Children's Hospital, Salt Lake City, Utah, USA.
Young DC; Intermountain Healthcare, Primary Children's Cystic Fibrosis Pediatric Center, Salt Lake City, Utah, USA.

Pediatr Pulmonol ; 55(12): 3541-3572, 2020 12.

Article en En | MEDLINE | ID: mdl-32946194

Asunto(s)

Antiinfecciosos/uso terapéutico; Aspergilosis Broncopulmonar Alérgica/tratamiento farmacológico; Fibrosis Quística/complicaciones; Adolescente; Corticoesteroides/uso terapéutico; Adulto; Anfotericina B/uso terapéutico; Anticuerpos Monoclonales/uso terapéutico; Antifúngicos/uso terapéutico; Niño; Fibrosis Quística/tratamiento farmacológico; Femenino; Humanos; Itraconazol/uso terapéutico; Omalizumab/uso terapéutico; Voriconazol/uso terapéutico

Palabras clave

ABPA; anti-fungal therapy; corticosteroids; cystic fibrosis; pharmacology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Aspergilosis Broncopulmonar Alérgica / Fibrosis Quística / Antiinfecciosos Idioma: En Revista: Pediatr Pulmonol Asunto de la revista: PEDIATRIA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google